These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17921034)

  • 1. Targeting the treatment of drug abuse with molecular imaging.
    Schiffer WK; Liebling CN; Patel V; Dewey SL
    Nucl Med Biol; 2007 Oct; 34(7):833-47. PubMed ID: 17921034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging studies in drug abuse.
    Fowler JS; Volkow ND
    J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-animal positron emission tomography as a tool for neuropharmacology.
    Lancelot S; Zimmer L
    Trends Pharmacol Sci; 2010 Sep; 31(9):411-7. PubMed ID: 20599282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human brain imaging and substance abuse.
    Lingford-Hughes A
    Curr Opin Pharmacol; 2005 Feb; 5(1):42-6. PubMed ID: 15661624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging the neurochemistry of alcohol and substance abuse.
    Martinez D; Kim JH; Krystal J; Abi-Dargham A
    Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-specific delivery of peptide-based probes for PET imaging.
    Chen K; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1005-22. PubMed ID: 20851156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporter gene imaging: potential impact on therapy.
    Serganova I; Blasberg R
    Nucl Med Biol; 2005 Oct; 32(7):763-80. PubMed ID: 16243653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-generation radiotracers for nAChR and NET.
    Ding YS; Fowler J
    Nucl Med Biol; 2005 Oct; 32(7):707-18. PubMed ID: 16243646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?
    Schirrmacher R; Bernard-Gauthier V; Reader A; Soucy JP; Schirrmacher E; Wängler B; Wängler C
    Future Med Chem; 2013 Sep; 5(14):1621-34. PubMed ID: 24047268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging addiction with PET: is insight in sight?
    Schiffer WK; Lee DE; Brodie JD; Dewey SL
    Drug Discov Today; 2005 Apr; 10(8):547-62. PubMed ID: 15837598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography: Updates on Imaging of Addiction.
    Solingapuram Sai JKK; Hurley RA; Dodda M; Taber KH
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):A6-288. PubMed ID: 31613195
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptor targeting agents for imaging inflammation/infection: where are we now?
    Signore A; Chianelli M; D'Alessandria C; Annovazzi A
    Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics.
    Ernst M; Kimes AS; Jazbec S
    Neuroimaging Clin N Am; 2003 Nov; 13(4):833-49. PubMed ID: 15024965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.